Policy
Editorial policy
How content is written, sourced, reviewed and approved before it appears.
Last updated 17 August 2026.
This policy describes how content reaches the public site. It is enforced partly by process and partly by the build itself: a record that has not been approved does not generate a page.
Sourcing
- Substantive scientific claims are sourceable. Where a claim cannot be sourced, it is removed rather than softened.
- Papers, authors, identifiers and trial numbers are never invented. A citation that has not been checked carries a visible unverified marker rather than passing silently.
- Primary research and official sources are preferred. Review articles and secondary sources are labelled as such.
- Regulatory statements link to the authoritative source and are not inferred from context, from other jurisdictions, or from how a product is marketed.
- Sources that change over time carry an access date.
Language about evidence
- Evidence is reported by level: in vitro, animal, early human, established clinical. Levels are never merged.
- Absence of evidence is stated explicitly. A section is never left blank to imply nothing needs saying.
- Cautious constructions such as “has been investigated in” are used in preference to “treats” or “works for”.
- Mechanisms under investigation are not presented as demonstrated outcomes.
Approval
Every compound record enters the dataset marked as requiring both scientific and regulatory review. Approval requires a completed scientific review, a completed regulatory review with a cited source, a written safety interpretation and at least one reference. A record whose regulatory status is unconfirmed, prescription-only, unlicensed or experimental cannot be approved without an explicit sourced sign-off, and the build fails if it is.
What this site does not publish
No pricing, availability, ordering routes, discount codes, testimonials, before-and-after imagery, dosage calculators, cycle protocols, reconstitution calculators or administration instructions. No metadata is written to attract transactional searches for medicines, and no product or offer structured data is emitted.